Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease

Saved in:
Bibliographic Details
Published inGastroenterology (New York, N.Y. 1943) Vol. 161; no. 6; pp. 2041 - 2043.e1
Main Authors Pozdnyakova, VALERIYA, Botwin, GREGORY J., Sobhani, KIMIA, Prostko, JOHN, Braun, JONATHAN, Mcgovern, DERMOT P.B., Melmed, GIL Y., Appel, Keren, Banty, Andrea, Feldman, Edward, Ha, Christina, Kumar, Rashmi, Lee, Susie, Rabizadeh, Shervin, Stein, Theodore, Syal, Gaurav, Targan, Stephan, Vasiliauskas, Eric, Ziring, David, Debbas, Philip, Hampton, Melissa, Mengesha, Emebet, Stewart, James L., Frias, Edwin C., Cheng, Susan, Ebinger, Joseph, Figueiredo, Jane C., Boland, Brigid, Charabaty, Aline, Chiorean, Michael, Cohen, Erica, Flynn, Ann, Valentine, John, Fudman, David, Horizon, Arash, Hou, Jason, Hwang, Caroline, Lazarev, Mark, Lum, Donald, Fausel, Rebecca, Reddy, Swapna, Mattar, Mark, Metwally, Mark, Ostrov, Arthur, Parekh, Nimisha, Raffals, Laura, Sheibani, Sarah, Siegel, Corey, Wolf, Douglas, Younes, Ziad
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.12.2021
by the AGA Institute
Subjects
Research Letter
COVID-19
IMT
SARS-CoV-2
IBD
mRNA
CI
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0016-5085
1528-0012
1528-0012
DOI:10.1053/j.gastro.2021.08.014